Amphastar Pharmaceuticals Inc (AMPH)
47.65
+1.56
(+3.38%)
USD |
NASDAQ |
Nov 08, 10:06
Amphastar Pharmaceuticals Revenue (TTM): 723.55M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2024 | 723.55M |
June 30, 2024 | 712.89M |
March 31, 2024 | 676.21M |
December 31, 2023 | 644.40M |
September 30, 2023 | 601.31M |
June 30, 2023 | 540.89M |
March 31, 2023 | 518.64M |
December 31, 2022 | 498.99M |
September 30, 2022 | 484.85M |
June 30, 2022 | 476.92M |
March 31, 2022 | 455.12M |
December 31, 2021 | 437.77M |
September 30, 2021 | 412.80M |
June 30, 2021 | 384.04M |
March 31, 2021 | 368.18M |
December 31, 2020 | 349.85M |
September 30, 2020 | 337.31M |
June 30, 2020 | 334.01M |
March 31, 2020 | 327.26M |
December 31, 2019 | 322.36M |
September 30, 2019 | 328.66M |
June 30, 2019 | 324.07M |
Date | Value |
---|---|
March 31, 2019 | 316.06M |
December 31, 2018 | 294.67M |
September 30, 2018 | 265.38M |
June 30, 2018 | 247.75M |
March 31, 2018 | 241.90M |
December 31, 2017 | 240.18M |
September 30, 2017 | 243.32M |
June 30, 2017 | 249.62M |
March 31, 2017 | 252.47M |
December 31, 2016 | 255.16M |
September 30, 2016 | 268.53M |
June 30, 2016 | 268.18M |
March 31, 2016 | 254.00M |
December 31, 2015 | 251.52M |
September 30, 2015 | 230.48M |
June 30, 2015 | 226.33M |
March 31, 2015 | 221.48M |
December 31, 2014 | 210.46M |
September 30, 2014 | 209.46M |
June 30, 2014 | 209.07M |
March 31, 2014 | 222.59M |
December 31, 2013 | 229.68M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
322.36M
Minimum
Dec 2019
723.55M
Maximum
Sep 2024
480.37M
Average
466.02M
Median
Revenue (TTM) Benchmarks
Omeros Corp | -- |
Harrow Inc | 154.15M |
PetIQ Inc | 1.134B |
Alector Inc | 61.51M |
Outset Medical Inc | 114.73M |